Abstract
To obtain approval from the Food and Drug Administration (FDA) or an equivalent agency outside the United States to market and sell a new drug or biologic product for use in humans, a series of clinical studies must be performed. These clinical studies exist in four phases. Each phase has specific and differing requirements for patient types, goals, inclusion/exclusion criteria, design features, and expected outcomes. Combined, they build the patient care database for safety and efficacy that hopefully will lead to product approval.
Original language | English (US) |
---|---|
Title of host publication | Drug and Biological Development |
Subtitle of host publication | From Molecule to Product and Beyond |
Publisher | Springer US |
Pages | 107-122 |
Number of pages | 16 |
ISBN (Print) | 9780387329789 |
DOIs | |
State | Published - Dec 1 2007 |
ASJC Scopus subject areas
- General Medicine
- General Agricultural and Biological Sciences